Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest

• Status: Completed
• Trial end date: 2019-06-02
• Target enrollment: 0
• Participant gender: All

Summary

To study the effects of ubiquinol as a "metabolic resuscitator" in post-cardiac arrest.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beth Israel Deaconess Medical Center
• Collaborators: Kaneka Medical America LLC; Kaneka Pharma America LLC
• Treatments: Ubiquinone

Criteria

Inclusion Criteria:

• Adult (≥ 18 years)

• Cardiac arrest defined by cessation of pulse requiring chest compressions

• Not following commands after ROSC

• Admission to the ICU

• Naso/orogastric tube

• Ability to receive enteral medication

Exclusion Criteria:

• Protected populations (pregnant women, prisoners, the intellectual disabled)

• Current CoQ10 supplementation

• Anticipated death within 24 hours

• > 12 hours from ROSC to estimated randomization

• Jejunostomy tube (J-tube)